Funded Startups in Hefa
Among the 49 listed rounds, the largest disclosed amount is proteanTecs’ $51M (Series D) on 2025-09-14.
Among the 49 listed rounds, the largest disclosed amount is proteanTecs’ $51M (Series D) on 2025-09-14. That single figure sits above the next-largest disclosed amounts in the list’s $40M–$35M band (e.g., MedicannX $70M on 2024-07-28 and InSightec $150M on 2024-06-18 are actually larger, so proteanTecs is not the top-of-list by amount; instead, the dataset’s top disclosed amount is InSightec at $150M on 2024-06-18, which dwarfs the rest). The most recent round date shown is 2025-09-17 (Feelit, Series A, $8M), while the oldest is 2020-03-20 (Pruvo, AI, amount $1M), spanning about five years.
Clustering shows up both by geography and stage: Haifa appears repeatedly across companies (e.g., Feelit in Haifa/Hefa on 2025-09-17; proteanTecs on 2025-09-14; Minovia is in Tirat Carmel), and many biotech and AI names recur across adjacent quarters in 2023–2024 (e.g., OncoHost $35M on 2022-05-10; MeMed $93M on 2022-01-10; NeuReality shows $20M on 2024-03-19 and $8M on 2021-02-10). On classifications, a large share of rounds is “Series Unknown” or undisclosed: “Series Unknown” appears on multiple entries (including Minovia $350K on 2025-08-27; MedicannX $70M on 2024-07-28; OncoHost is Series C instead), and “undisclosed” amounts recur (e.g., Sensifai Health on 2025-07-02).
Most recent rounds
49 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Hefa list, and how separated is it from the next-largest disclosed deals?
InSightec’s $150M (2024-06-18, “Series Unknown”) is the top disclosed amount in the 49 rows, clearly above the rest; the next-largest disclosed figures shown include MedicannX $70M (2024-07-28) and MeMed $93M (2022-01-10), while proteanTecs’ $51M (2025-09-14) is still high but not close to the $150M outlier.
Do rounds cluster in time within the most recent window, or are they evenly spread across years?
The list is temporally concentrated near 2024–2025: the three most recent rounds are 2025-09-17 (Feelit, $8M), 2025-09-14 (proteanTecs, $51M), and 2025-08-27 (Minovia, $350K), and there are multiple entries in mid-2024 such as InSightec $150M (2024-06-18) and MedicannX $70M (2024-07-28). Earlier years still appear (e.g., Pruvo $1M on 2020-03-20), but the newest months contain the densest run.
Which stage naming patterns dominate, and do undisclosed amounts materially affect comparisons?
Stage labels skew toward “Series Unknown” and non-standard buckets (e.g., MeMed is “Venture - Series Unknown” on 2022-01-10 for $93M; MedicannX is “Series Unknown” on 2024-07-28 for $70M), and “undisclosed” amounts show up on multiple rows (e.g., Sensifai Health on 2025-07-02, and several 2023–2022 entries with undisclosed amounts). Because undisclosed rows can’t be compared by amount, disclosed outliers like InSightec $150M stand out even more.
Are there city-level concentrations within the Hefa label (and how do naming variants affect that)?
Haifa/Hefa is the most repeated city string: Feelit (Haifa, Hefa, Israel; 2025-09-17), proteanTecs (Haifa, Hefa, Israel; 2025-09-14), Droxi (Haifa, Hefa, Israel; 2024-12-03), and several others list Haifa explicitly. Other municipalities also recur—Caesarea, Tirat Carmel, and Binyamina appear frequently—so the pattern is broader than one single city, but Haifa is the clearest hub by repetition.
Which sectors show up often enough to form a cluster rather than one-offs?
Artificial Intelligence (AI) recurs across multiple dated rounds: Sensifai Health (2025-07-02, Seed, undisclosed), Droxi (2024-12-03, Series A, $21M), NeuReality (2024-03-19, amount $20M with blank stage), and several other AI-labeled entries including Pruvo (2020-03-20, $1M). Biotechnology also clusters, with multiple large disclosed deals such as InSightec $150M (2024-06-18), MedicannX $70M (2024-07-28), and MeMed $93M (2022-01-10).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.